Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Ropert

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
The Lancet. Oncology|November 29, 2008
Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcomaOlivier Mir, Stanislas Ropert, François Goldwasser
The New England Journal of Medicine|July 9, 2020
EndometriosisPaul Berveiller, Stanislas Ropert, Olivier Mir
The Lancet. Oncology|March 6, 2009
Cisplatin as a cornerstone of modern chemotherapyOlivier Mir, Stanislas Ropert, François Goldwasser
Bulletin Du Cancer|September 13, 2007
[Oral drugs inhibiting the VEGF pathway]Stanislas Ropert, Olivier Mir, Jean-Pierre Armand
Bulletin Du Cancer|April 21, 2012
[Management of metastatic castration-resistant prostate cancer following docetaxel]Philippe Beuzeboc, Stanislas Ropert, François Goldwasser, et al.
Mayo Clinic Proceedings|December 7, 2019
Clinical Activity of Sunitinib and Regorafenib in EndometriosisOlivier Mir, Stanislas Ropert, Philippe Morice, et al.
Investigational New Drugs|August 3, 2010
VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruptionStanislas Ropert, Olivier Vignaux, Olivier Mir, et al.
Cancer|November 6, 2008
Use of platinum derivatives during pregnancyOlivier Mir, Paul Berveiller, Stanislas Ropert, et al.
BJR Case Reports|December 22, 2025
Peritoneal metastases from colorectal cancer managed by stereotactic body radiation therapy: presentation of a clinical case and review of literatureAlexander Bennassi, Stanislas Ropert, Gokoulakrichenane Loganadane, et al.
Acta Oncologica (Stockholm, Sweden)|October 25, 2016
Hepatitis B reactivation during everolimus treatmentOlivier Mir, Maud Toulmonde, Romain Coriat, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
The Lancet. Oncology|November 29, 2008
Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcomaOlivier Mir, Stanislas Ropert, François Goldwasser
The New England Journal of Medicine|July 9, 2020
EndometriosisPaul Berveiller, Stanislas Ropert, Olivier Mir
The Lancet. Oncology|March 6, 2009
Cisplatin as a cornerstone of modern chemotherapyOlivier Mir, Stanislas Ropert, François Goldwasser
Bulletin Du Cancer|September 13, 2007
[Oral drugs inhibiting the VEGF pathway]Stanislas Ropert, Olivier Mir, Jean-Pierre Armand
Bulletin Du Cancer|April 21, 2012
[Management of metastatic castration-resistant prostate cancer following docetaxel]Philippe Beuzeboc, Stanislas Ropert, François Goldwasser, et al.
Mayo Clinic Proceedings|December 7, 2019
Clinical Activity of Sunitinib and Regorafenib in EndometriosisOlivier Mir, Stanislas Ropert, Philippe Morice, et al.
Investigational New Drugs|August 3, 2010
VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruptionStanislas Ropert, Olivier Vignaux, Olivier Mir, et al.
Cancer|November 6, 2008
Use of platinum derivatives during pregnancyOlivier Mir, Paul Berveiller, Stanislas Ropert, et al.
BJR Case Reports|December 22, 2025
Peritoneal metastases from colorectal cancer managed by stereotactic body radiation therapy: presentation of a clinical case and review of literatureAlexander Bennassi, Stanislas Ropert, Gokoulakrichenane Loganadane, et al.
Acta Oncologica (Stockholm, Sweden)|October 25, 2016
Hepatitis B reactivation during everolimus treatmentOlivier Mir, Maud Toulmonde, Romain Coriat, et al.
Pageof 6